scholarly article | Q13442814 |
P50 | author | Ritsuko Komaki | Q64585410 |
P2093 | author name string | Ting Xu | |
Lili Wang | |||
Qingyi Wei | |||
Zhensheng Liu | |||
Daniel R Gomez | |||
Zhongxing Liao | |||
Ning Gu | |||
Hongliang Liu | |||
Xiaomeng Wang | |||
Juyi Wen | |||
P2860 | cites work | Global cancer statistics | Q22241238 |
Cloning and analysis of human Apg16L | Q24336706 | ||
The Atg16L complex specifies the site of LC3 lipidation for membrane biogenesis in autophagy | Q24647053 | ||
Autophagy in non-small cell lung carcinogenesis: A positive regulator of antitumor immunosurveillance | Q27011517 | ||
Definitive radiotherapy in locally advanced non-small cell lung cancer: dose and fractionation | Q27027626 | ||
Single Nucleotide Polymorphisms in CBLB, a Regulator of T-Cell Response, Predict Radiation Pneumonitis and Outcomes After Definitive Radiotherapy for Non-Small-Cell Lung Cancer | Q27853314 | ||
Autophagy in the Pathogenesis of Disease | Q27860558 | ||
Autophagy fights disease through cellular self-digestion | Q27860902 | ||
High-resolution profiling of histone methylations in the human genome | Q27860906 | ||
Suppression of basal autophagy in neural cells causes neurodegenerative disease in mice | Q28131756 | ||
Autophagy: renovation of cells and tissues | Q29547206 | ||
Autophagy: from phenomenology to molecular understanding in less than a decade | Q29614174 | ||
The Atg1-Atg13 complex regulates Atg9 and Atg23 retrieval transport from the pre-autophagosomal structure | Q29614179 | ||
Assessing the probability that a positive report is false: an approach for molecular epidemiology studies | Q29616285 | ||
Dynamics and diversity in autophagy mechanisms: lessons from yeast | Q29620685 | ||
Role of genetic variants of autophagy genes in susceptibility for non-medullary thyroid cancer and patients outcome | Q31158779 | ||
The two C. elegans ATG-16 homologs have partially redundant functions in the basal autophagy pathway | Q33638704 | ||
Genotypes and haplotypes of the VEGF gene and survival in locally advanced non-small cell lung cancer patients treated with chemoradiotherapy | Q33659635 | ||
Inflammasome-independent modulation of cytokine response by autophagy in human cells | Q33872210 | ||
Prognostic significance of p62/SQSTM1 subcellular localization and LC3B in oral squamous cell carcinoma | Q34113510 | ||
Phospho-ΔNp63α/miR-885-3p axis in tumor cell life and cell death upon cisplatin exposure | Q34231282 | ||
Increased expression of ATG10 in colorectal cancer is associated with lymphovascular invasion and lymph node metastasis | Q34534491 | ||
Frameshift mutations of autophagy-related genes ATG2B, ATG5, ATG9B and ATG12 in gastric and colorectal cancers with microsatellite instability | Q34938849 | ||
Autophagy controls BCG-induced trained immunity and the response to intravesical BCG therapy for bladder cancer | Q35377891 | ||
Polymorphisms in autophagy genes are associated with paget disease of bone | Q35647920 | ||
MiR-200b regulates autophagy associated with chemoresistance in human lung adenocarcinoma | Q36544983 | ||
Does autophagy contribute to cell death? | Q36549462 | ||
Autophagy-related gene 12 (ATG12) is a novel determinant of primary resistance to HER2-targeted therapies: utility of transcriptome analysis of the autophagy interactome to guide breast cancer treatment | Q36926125 | ||
Identification of a Systemic Lupus Erythematosus Risk Locus Spanning ATG16L2, FCHSD2, and P2RY2 in Koreans | Q37168051 | ||
Increased ATG5-ATG12 in hepatitis B virus-associated hepatocellular carcinoma and their role in apoptosis. | Q37322455 | ||
miR-494-3p is a novel tumor driver of lung carcinogenesis | Q37702495 | ||
Non-small-cell lung cancer. | Q37874768 | ||
The autophagosome: origins unknown, biogenesis complex | Q38160660 | ||
MicroRNA-181a-5p Impedes IL-17-Induced Nonsmall Cell Lung Cancer Proliferation and Migration through Targeting VCAM-1. | Q38288067 | ||
Autophagy and its function in radiosensitivity | Q38462513 | ||
Role of ATG10 expression quantitative trait loci in non-small cell lung cancer survival | Q38768455 | ||
Functional variants in DCAF4 associated with lung cancer risk in European populations | Q38850374 | ||
Autophagy is not uniformly cytoprotective: a personalized medicine approach for autophagy inhibition as a therapeutic strategy in non-small cell lung cancer | Q38868651 | ||
Crosstalk between autophagy and intracellular radiation response (Review). | Q38982588 | ||
Cancer Statistics, 2017. | Q39038674 | ||
A genome-wide screen identifies frequently methylated genes in haematological and epithelial cancers | Q39628888 | ||
Autophagy Inhibition Dysregulates TBK1 Signaling and Promotes Pancreatic Inflammation. | Q40805952 | ||
Atg16L2, a novel isoform of mammalian Atg16L that is not essential for canonical autophagy despite forming an Atg12–5-16L2 complex | Q41879755 | ||
Mammalian Atg2 proteins are essential for autophagosome formation and important for regulation of size and distribution of lipid droplets. | Q41978043 | ||
Tumor suppression and promotion by autophagy | Q42136875 | ||
ATG2B and GSKIP: 2 new genes predisposing to myeloid malignancies | Q42729833 | ||
Radiation pneumonitis following combined modality therapy for lung cancer: analysis of prognostic factors | Q46620100 | ||
Potentially functional polymorphisms in ATG10 are associated with risk of breast cancer in a Chinese population | Q48014761 | ||
Polypyrimidine tract-binding protein 1-mediated down-regulation of ATG10 facilitates metastasis of colorectal cancer cells. | Q51331419 | ||
A functional variant of ATG16L2 is associated with Crohn's disease in the Chinese population. | Q51526002 | ||
The Thr300Ala variant of ATG16L1 is associated with decreased risk of brain metastasis in patients with non-small cell lung cancer. | Q52097466 | ||
Large decreases in standardized uptake values after definitive radiation are associated with better survival of patients with locally advanced non-small cell lung cancer. | Q53180625 | ||
Autophagy-related gene16L2, a potential serum biomarker of multiple sclerosis evaluated by bead-based proteomic technology. | Q54228403 | ||
The American Joint Committee on Cancer: updating the strategies in cancer staging | Q80045965 | ||
P577 | publication date | 2018-02-15 | |
P1433 | published in | Journal of Thoracic Oncology | Q2448056 |
P1476 | title | Potentially Functional variants of ATG16L2 predict radiation pneumonitis and outcomes in patients with non-small cell lung cancer after definitive radiotherapy |
Q64277031 | Emphysema quantification on computed tomography and its value in predicting radiation pneumonitis in lung cancer treated by stereotactic body radiotherapy |
Q92501494 | Impact of genetic variant of HIPK2 on the risk of severe radiation pneumonitis in lung cancer patients treated with radiation therapy |
Q97539571 | Novel genetic variants of KIR3DL2 and PVR involved in immunoregulatory interactions are associated with non-small cell lung cancer survival |
Q90012768 | Precise prediction of the radiation pneumonitis in lung cancer: an explorative preliminary mathematical model using genotype information |
Q92016948 | Risk factors of grade ≥ 2 radiation pneumonitis after gemcitabine induction chemotherapy for patients with non-small cell lung cancer |
Q103826099 | Role of PARP1-mediated autophagy in EGFR-TKI resistance in non-small cell lung cancer |